On July 29, JD HEALTH rose 3.06% in regular trading, trading at HK$39.32/share, with turnover of HK$17.67 million. The stock was supported by multiple recent positive catalysts including a comprehensive health checkup service upgrade and a significant share buyback cancellation.
On July 24, JD HEALTH announced a full upgrade of its health checkup services, introducing three key initiatives: free re-examination within 180 days for over 200 positive indicators, a dedicated 1-on-1 private doctor team for checkup accompaniment, and closed-loop management covering diagnosis, testing, treatment and medication for abnormal indicators. On the same day, the company opened its Beijing Ya'ao comprehensive outpatient clinic spanning 5,800 square meters, offering health checkups, dental, and medical aesthetics services.
Additionally, on July 22, JD HEALTH completed the cancellation of approximately 21.54 million repurchased shares at a total cost of approximately HK$839 million, reducing issued share capital to approximately 3.19 billion shares. Goldman Sachs also recently maintained a Buy rating on the stock, citing continued market share expansion.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments